Was quote from the CEO in a iii media presentation and it was looking forward to fully developed pipeline of successful drugs. Many years into the future. I'd be quite happy with the 1p too then top slice and bank the rest is free shares. As far as being a dodgy share all the research pharmas have a poor reputation because they're so many stages at which they can go wrong, run out of money or be upstaged by some other company with a better product. For me this was an out and out punt based on the SP bottoming, reasonable cash flow with a little bit of income from current products, and approaching the human stage of testing. It's one I'm willing to wait on with money I can afford to lose. I have the shares which are safer bets but it's fun to dream and the CEO is right this could possibly go beyond blue skies on a mission to Mars. This isn't the bang whoosh play to make a few pennies next week it's a long-term play with some short-term goals a penny being one of them.
we would see the sp to jump to £6 per share but it doesn't look like that way, oh well bad luck. But it is imminent so just hang on in there like I have been...It looks like I have to sell another house to get another million shares if it is a bit lower..Have good weekend.
need crap sentiment as i said the other day so please all of the doom merchants can you scare away the tenner profiteers please theres good chaps ,,,,,,,,,,,,the market is a cruel uncanny slippery eel !
Fair enough. Thanks Harley. I'm happy with what I've researched here and what we know could happen. I've been in here for a good 2 years or so and will continue to wait. Thanks for the tip SmartVestor, I'll have a look.
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.